drugset / Trial / NCT03961126

Evaluation of Vulvar Lichen Sclerosus Treatment Using Adipose Tissue Associated With Autologous Platelet-rich Plasma.

NCT03961126

Phase 2 Completed 20 enrolled La Fe Health Research Institute
RandomizedParallel-groupOpen-labelTreatment

Summary

LIQUENIA clinical trial is a phase II, controlled, prospective and unicentric study to assess vulvar lichen sclerosus (VLS) treatment using adipose tissue associated with autologous platelet-rich plasma (PRP) coming from the inner side of the patients' thighs, which aims to restore the structure and elasticity of the affected vulvar subunits, and to improve vulvar subunits lesions and symptoms, therefore, patients' quality of life from the early phases of the treatment.

Timeline

Start
2017-09-06
Primary completion
2019-12-12
Completion
2019-12-12

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Clobetasol Small molecule 0.05 % Topical
Subject Platelet Rich Plasma Other / unclassified 4 ml Other
Subject autologous fatty tissue Unknown 20 ml Other